Body

Follow-up visits conducted via a secure Web site may result in similar clinical outcomes as in-person visits among patients with acne, according to a report in the April issue of Archives of Dermatology, one of the JAMA/Archives journals.

Patients who receive an audiotape of their consultation before undergoing heart surgery appear to have more knowledge about their procedures and their health, and also have reduced anxiety and depression, according to a report in the April issue of Archives of Surgery, one of the JAMA/Archives journals.

Individuals who are exposed to more secondhand smoke in private and public settings appear more likely to have chronic rhinosinusitis, according to a report in the April issue of Archives of Otolaryngology–Head & Neck Surgery, one of the JAMA/Archives journals.

Cases of foreign bodies obstructing the airways of young children occur infrequently, but the death rate from such events is high, according to a report in the April issue of Archives of Otolaryngology–Head & Neck Surgery, one of the JAMA/Archives journals.

"Bureaucracy is the death of all sound work," said Albert Einstein, sharing a popular view about bureaucracy grinding progress to a halt.

WASHINGTON, D.C. — Metformin, a mainstay of treatment for patients with type 2 diabetes, may soon play a role in lung cancer prevention if early laboratory research presented here at the AACR 101st Annual Meeting 2010 is confirmed in clinical trials.

Metformin decreases levels of insulin-like growth factor-1 (IGF-1) and circulating insulin, which is important in patients with type 2 diabetes. However, emerging research suggests metformin may inhibit tumor growth as well.

Montreal, April 19, 2010 – Low back pain (or lumbago) is a common ailment often triggered by something as simple as lifting a suitcase. What is the best way to remedy the situation? An exercise machine designed specifically for back muscles could be the solution according to a new study published in the Journal of the American College of Sports Medicine.

ANN ARBOR, Mich. — A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study from researchers at the University of Michigan Comprehensive Cancer Center finds.

RICHMOND, Va. (April 19, 2010) – Virginia Commonwealth University researchers have identified a new tumor-promoting gene that may play a key role in the development of liver cancer. Levels of the gene's expression are significantly higher in more than 90 percent of patients with the disease compared to their healthy counterparts.

Scientists and engineers have used uniform magnetic fields to drive iron-bearing nanoparticles to metal stents in injured blood vessels, where the particles deliver a drug payload that successfully prevents blockages in those vessels. In this animal study, the novel technique achieved better results at a lower dose than conventional non-magnetic stent therapy.

BINGHAMTON, NY – In each of two cities, a team of local agencies launches a campaign to keep children from joining gangs. The two use similar tactics, combining counseling, tutoring and recreation. One initiative shows great results; the other makes barely a dent. Why the difference?

The research of Pamela Mischen, associate professor of public administration at Binghamton University, demonstrates that one program may have failed because the right people weren't talking.

Washington, DC – A high level of one type of estrogen in a man's body might increase his risk of developing prostate cancer. That is one surprising conclusion from a new study which also offers another novel finding – that high levels of the estrogen considered fuel for breast cancer might offer a protective benefit against prostate cancer. Details of the research will be presented at the AACR 101st Annual Meeting 2010.

WASHINGTON, D.C. — Researchers at Johns Hopkins have evaluated a simple, more specific blood test that identifies patients undergoing proactive surveillance for low-grade, low-stage, non-palpable prostate cancer who would eventually require treatment.

These results, presented at the American Association for Cancer Research 101st Annual Meeting 2010, may be a major advance in prostate cancer risk assessment.

PHILADELPHIA (April 19, 2010)—Lung cancer rates are increasing substantially in women, particularly in non-smoking women, with no known reason for the increase. Now researchers at Fox Chase Cancer Center may have uncovered a critical piece in the puzzle.

WASHINGTON, D.C. (April 19, 2010)––Most treatment for advanced head and neck cancer requires chemotherapy with a drug called cisplatin, an inorganic platinum agent that inhibits cell growth. A substantial number of patients do not respond well to this therapy, but oncologists are unable to prescribe alternative agents because they don't know which patients will respond to platinum therapy and which won't.